{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:15Z","timestamp":1791897915299,"version":"4.3.4"},"reference-count":32,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"23","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2023,8,10]]},"abstract":"<jats:sec><jats:title>PURPOSE<\/jats:title><jats:p> Patients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment consists of curative intent combined modality therapy (neoadjuvant chemotherapy, surgery, and regional radiation). Positron emission tomography-computed tomography (PET-CT) may detect more asymptomatic distant metastases, but the evidence is based on uncontrolled studies. <\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p> For inclusion, patients had histological evidence of invasive ductal carcinoma of the breast and TNM stage III or IIb (T3N0, but not T2N1). Consenting patients from six regional cancer centers in Ontario were randomly assigned to <jats:sup>18<\/jats:sup>F-labeled fluorodeoxyglucose PET-CT or conventional staging (bone scan, CT of the chest\/abdomen and pelvis). The primary end point was upstaging to stage IV. A key secondary outcome was receiving curative intent combined modality therapy (ClinicalTrials.gov identifier: NCT02751710 ). <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p> Between December 2016 and April 2022, 184 patients were randomly assigned to whole-body PET-CT and 185 patients to conventional staging. Forty-three (23%) PET-CT patients were upstaged to stage IV compared with 21 (11%) conventional staged patients (absolute difference, 12.3% [95% CI, 3.9 to 19.9]; P = .002). Consequently, treatment was changed in 35 (81.3%) of 43 upstaged PET-CT patients and 20 (95.2%) of the 21 upstaged conventional patients. Subsequently, 149 (81%) patients in the PET-CT group received combined modality treatment versus 165 (89.2%) patients in the conventional staging group (absolute difference, 8.2% [95% CI, 0.1 to 15.4]; P = .03). <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p> In patients with LABC, PET-CT detected more distant metastases than conventional staging, and fewer PET-CT patients received combined modality therapy. Our randomized trial demonstrates the utility of the PET-CT staging strategy. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.23.00249","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T20:00:50Z","timestamp":1685131250000},"page":"3909-3916","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":55,"title":["Impact of <sup>18<\/sup>F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer"],"prefix":"10.1200","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct02751710","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8550-1485","authenticated-orcid":false,"given":"Ian S.","family":"Dayes","sequence":"first","affiliation":[{"name":"Department of Oncology, McMaster University, Hamilton, ON, Canada"},{"name":"Juravinski Cancer Centre\u2014Hamilton Health Sciences, Hamilton, ON, Canada"},{"name":"Ontario Clinical Oncology Group, Hamilton, ON, Canada"},{"name":"Escarpment Cancer Research Institute, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-8994","authenticated-orcid":false,"given":"Ur","family":"Metser","sequence":"additional","affiliation":[{"name":"Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"},{"name":"University Health Network Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Department of Surgery, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Parpia","sequence":"additional","affiliation":[{"name":"Department of Oncology, McMaster University, Hamilton, ON, Canada"},{"name":"Ontario Clinical Oncology Group, Hamilton, ON, Canada"},{"name":"Escarpment Cancer Research Institute, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea F.","family":"Eisen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Sunnybrook Health Sciences Centre\u2014Odette Cancer Centre, Toronto, ON, Canada"},{"name":"Ontario Health, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1457-1229","authenticated-orcid":false,"given":"Ralph","family":"George","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, ON, Canada"},{"name":"St Michael's Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Blanchette","sequence":"additional","affiliation":[{"name":"Department of Oncology, Western University, London, ON, Canada"},{"name":"London Health Sciences Regional Cancer Program, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-6358","authenticated-orcid":false,"given":"Tulin D.","family":"Cil","sequence":"additional","affiliation":[{"name":"University Health Network Princess Margaret Cancer Centre, Toronto, ON, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Arnaout","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ottawa University, Ottawa, ON, Canada"},{"name":"Ottawa Hospital Cancer Centre, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Chan","sequence":"additional","affiliation":[{"name":"Northern Ontario School of Medicine, Thunder Bay ON, Canada"},{"name":"Thunder Bay Regional Health Sciences Cancer Centre, Thunder Bay, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-0773","authenticated-orcid":false,"given":"Mark N.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Oncology, McMaster University, Hamilton, ON, Canada"},{"name":"Juravinski Cancer Centre\u2014Hamilton Health Sciences, Hamilton, ON, Canada"},{"name":"Ontario Clinical Oncology Group, Hamilton, ON, Canada"},{"name":"Escarpment Cancer Research Institute, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.3747\/co.22.2697"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2009.05.003"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-6-521"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.13"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00427"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.106864"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.157859"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.143297"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-016-3570-6"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.182576"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-12"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.1103"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00132"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.7018"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.5504"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3740"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.151"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2081"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.1614"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4"},{"key":"b22","first-page":"690","volume":"58","author":"Mantel N","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-190707000-00001"},{"key":"b25","first-page":"3863","volume":"40","author":"Fisher B","year":"1980","journal-title":"Cancer Res"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03399"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01482"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq495"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-3-200908040-00125"},{"key":"b30","volume-title":"Initial National Priorities for Comparative Effectiveness Research","author":"Institute of Medicine","year":"2009"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.6706"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04553-8"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0030"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.23.00249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T22:00:17Z","timestamp":1691445617000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.00249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":32,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,8,10]]}},"alternative-id":["10.1200\/JCO.23.00249"],"URL":"https:\/\/doi.org\/10.1200\/jco.23.00249","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"2023-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}